mitoxantrone has been researched along with Animal Mammary Carcinoma in 4 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cunha, SC | 1 |
| Corgozinho, KB | 1 |
| Souza, HJ | 1 |
| Silva, KV | 1 |
| Ferreira, AM | 1 |
| Arenas, C | 1 |
| Peña, L | 1 |
| Granados-Soler, JL | 1 |
| Pérez-Alenza, MD | 1 |
| Lee, CM | 1 |
| Tannock, IF | 1 |
| Muleya, JS | 1 |
| Nakaichi, M | 1 |
| Taura, Y | 1 |
| Yamaguchi, R | 1 |
| Nakama, S | 1 |
4 other studies available for mitoxantrone and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Adjuvant chemotherapy with mitoxantrone for cats with mammary carcinomas treated with radical mastectomy.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Chemotherapy, Adjuvant; Combined Modality Therap | 2015 |
Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Case-Control Studies; Chemotherapy, Adjuvant; Cyclo | 2016 |
Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration.
Topics: Animals; Antibiotics, Antineoplastic; Antimalarials; Antineoplastic Agents; Breast Neoplasms; Chloro | 2006 |
In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Cell Division; Cisplatin; Dose-Response Relation | 1999 |